- All sections
- C - Chemistrymetallurgy
- C07D - Heterocyclic compounds
- C07D 519/04 - Dimeric indole alkaloids, e.g. vincaleucoblastine
Patent holdings for IPC class C07D 519/04
Total number of patents in this class: 63
10-year publication summary
|
4
|
6
|
6
|
5
|
4
|
4
|
3
|
5
|
1
|
1
|
| 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| ImmunoGen, Inc. | 376 |
6 |
| The Regents of the University of California | 20815 |
3 |
| Ablynx N.V. | 425 |
3 |
| Cascade Prodrug Inc. | 7 |
3 |
| The Scripps Research Institute | 1344 |
3 |
| Sun Pharmaceutical Industries Limited | 723 |
3 |
| Pfizer Inc. | 3409 |
2 |
| Centre National de La Recherche Scientifique | 11059 |
2 |
| Kunming Institute of Botany, Chinese Academy of Sciences | 34 |
2 |
| Pierre Fabre Medicament | 518 |
2 |
| Universite de Poitiers | 192 |
2 |
| Sorbonne Universite | 1406 |
2 |
| Janssen Pharmaceutica N.V. | 3160 |
1 |
| Bayer Pharma AG | 1009 |
1 |
| The Trustees of Columbia University in the City of New York | 3644 |
1 |
| Nichia Corporation | 3884 |
1 |
| CytRx Corporation | 12 |
1 |
| Indena S.p.A. | 595 |
1 |
| Infinity Pharmaceuticals, Inc. | 96 |
1 |
| Jiangsu Hansoh Pharmaceutical Co., Ltd. | 27 |
1 |
| Other owners | 22 |